Select language:

Russia starts human trials of COVID-19 vaccine

 / Главная / Russkiy Mir Foundation / News / Russia starts human trials of COVID-19 vaccine

Russia starts human trials of COVID-19 vaccine


Photo credit:

Trials of a new coronavirus vaccine on humans have begun, RIA Novosti reports. The work is being carried out by the Gamalei Research Center for Epidemiology and Microbiology and the Ministry of Defense.

The defense department explains that the first group of volunteers will be vaccinated as soon as the isolation period ends. The tests will help ensure that all components of the vaccine are safe for humans.

The Ministry of Health has already issued the permission for the testing. Of 50 selected volunteers, ten are medical professionals, including three doctors. Candidates who wish to participate in the project should not have chronic diseases that could impede research. Volunteers must be of both sexes, between the ages of 18 and 60, who have not previously had COVID-19.

According to Alexander Gunzburg, head of the Gamalei Center, the tests will continue for a month and a half. Volunteers will remain in the hospital for 28 days. Vaccination is planned in two stages. It will take place on day zero and on the 21st day.

Experts hope that the vaccine will be ready for launch in mass production in late summer, the first stage of vaccination may unfold in autumn.

Russkiy Mir

News by subject


Italian entrepreneur Marco Maggi's book, "Russian to the Bone," is now accessible for purchase in Italy and is scheduled for release in Russia in the upcoming months. In the book, Marco recounts his personal odyssey, narrating each stage of his life as a foreigner in Russia—starting from the initial fascination to the process of cultural assimilation, venturing into business, fostering authentic friendships, and ultimately, reaching a deep sense of identifying as a Russian at his very core.